These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 88801)

  • 41. Immune hemadsorption by cells infected with poxviruses.
    Miyamoto H; Kato S
    Biken J; 1968 Dec; 11(4):343-53. PubMed ID: 4305647
    [No Abstract]   [Full Text] [Related]  

  • 42. The inhibition of growth of vaccinia and cowpox viruses in RK 13 cells.
    Baxby D; Rondle CJ
    J Hyg (Lond); 1968 Jun; 66(2):191-205. PubMed ID: 4974738
    [No Abstract]   [Full Text] [Related]  

  • 43. Biochemical studies on early cell surface antigen induced by vaccinia and cowpox viruses.
    Ikuta K; Miyamoto H; Kato S
    J Gen Virol; 1980 Mar; 47(1):227-32. PubMed ID: 7365466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.
    Panicali D; Davis SW; Weinberg RL; Paoletti E
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5364-8. PubMed ID: 6310573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on the polypeptides of poxvirus. I. Comparison of structural polypeptides in vaccina, cowpox and Shope fibroma viruses.
    Ikuta K; Miyamoto H; Kato S
    Biken J; 1978 Jun; 21(2):51-61. PubMed ID: 219840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological and immunological characterization of influenza virus haemagglutinin expressed from the haemagglutinin locus of vaccinia virus.
    Itamura S; Morikawa Y; Shida H; Nerome K; Oya A
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1293-301. PubMed ID: 2351957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The biochemical and biological characteristics of the surface components of measles virus.
    Hall WW; Martin SJ
    J Gen Virol; 1974 Mar; 22(3):363-74. PubMed ID: 4818276
    [No Abstract]   [Full Text] [Related]  

  • 48. Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses.
    Mitra-Kaushik S; Cruz J; Stern LJ; Ennis FA; Terajima M
    J Immunol; 2007 Jul; 179(2):1303-12. PubMed ID: 17617623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orf virus and vaccinia virus do not cross-protect sheep.
    Robinson AJ; Mercer AA
    Arch Virol; 1988; 101(3-4):255-9. PubMed ID: 3178493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of anaplyxasis for evaluating the reactogenicity of commercial strains and series of a vaccine virus].
    Vorob'ev AA; Afanas'ev SS; Patrikeev GT; Podkuĭko VN; Pashanina TP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Aug; (8):14-7. PubMed ID: 494895
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experimental studies of hemagglutinating principle in animal pox viruses].
    MAYR A
    Arch Gesamte Virusforsch; 1956; 6(5):439-71. PubMed ID: 13340714
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies of a newly recognized poxvirus of monkeys.
    Crandell RA; Casey HW; Brumlow WB
    J Infect Dis; 1969 Jan; 119(1):80-8. PubMed ID: 4303797
    [No Abstract]   [Full Text] [Related]  

  • 53. Origin of the vaccinia virus hemagglutinin.
    Blackman KE; Bubel HC
    J Virol; 1972 Feb; 9(2):290-6. PubMed ID: 5062680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serological characterization of buffalopox virus.
    Lal SM; Singh IP
    Arch Gesamte Virusforsch; 1973; 43(4):393-6. PubMed ID: 4207285
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaccinia virus hemagglutinin.
    Shida H
    Subcell Biochem; 1989; 15():405-40. PubMed ID: 2678619
    [No Abstract]   [Full Text] [Related]  

  • 56. The vaccinia virus haemagglutinin: enzyme sensitivity and some physiocochemical properties.
    Gurvin I; Haukenes G
    Acta Pathol Microbiol Scand B; 1976 Aug; 84(4):165-9. PubMed ID: 60873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of the specificities of sequential antisera to variola and monkeypox viruses by radioimmunoassay.
    Walls HH; Ziegler DW; Nakano JH
    Bull World Health Organ; 1980; 58(1):131-8. PubMed ID: 6155223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.
    Taylor J; Weinberg R; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
    Virology; 1992 Mar; 187(1):321-8. PubMed ID: 1736535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on monkeypox virus.
    Rondle CJ; Sayeed KA
    Bull World Health Organ; 1972; 46(5):577-83. PubMed ID: 4538035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biogenesis of poxviruses: genetically controlled modifications of structural and functional components of the plasma membrane.
    Weintraub S; Dales S
    Virology; 1974 Jul; 60(1):96-127. PubMed ID: 4276314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.